Studies Show Benefits and Risks of Testosterone Treatment in Older Men
February 22, 2017
Coverage continues around the Testosterone Trials, led by Peter J. Snyder, MD, a professor of Medicine in the division of Endocrinology, Diabetes, and Metabolism, which found that testosterone treatment improved bone density and anemia for men over 65 with unequivocally low testosterone, but did not improve cognitive function, and increased the amount of plaque buildup in participants' coronary arteries. Snyder and co-author Susan Ellenberg, PhD, a professor of biostatistics, are quoted in several outlets.
Major Study Finds Testosterone Therapy is No Fountain of Youth
February 21, 2017
JAMA and JAMA Internal Medicine published final results from the TTrials, which shows testosterone treatment improved bone density and anemia for men over 65 with low testosterone, did not improve cognitive function, and increased the amount of plaque buildup in coronary arteries. Principal investigator Peter J. Snyder, MD, a professor of Medicine in Endocrinology, Diabetes and Metabolism, and co-author Susan Ellenberg, PhD, a professor of biostatistics, are quoted in NPR, Associated Press, and CNN stories, among others.
At N. Philly Middle School, Kids Learn to Look out for a Disease that Once Struck Only Grownups
February 6, 2017
The Philadelphia Inquirer featured the work of Mark Schutta, MD, director of the Rodebaugh Diabetes Center, and a team from the Center, who recently led a diabetes education assembly at St. Martin de Porres school in North Philadelphia. Students, along with caregivers and staff, were invited to attend to learn more about the prevalence and risk of type 2 diabetes, and they had the opportunity to receive a blood glucose screening.
Penn Researchers Receive $12 Million from National Institutes of Health to Establish Pancreas Research Program
December 21, 2016
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded Penn Medicine a $12 Million, four-year grant to establish the Human Pancreas Analysis Program (HPAP).
“The past decades have seen a dramatic improvement in our ability to profile human tissues relevant to Type 1 diabetes at the genomic, epigenomic, protein, and functional levels,” said Klaus H. Kaestner, PhD, the Thomas and Evelyn Suor Butterworth Professor in Genetics and associate director of the Penn Diabetes Research Center, in the Perelman School of Medicine at the University of Pennsylvania.
Molecular “Pillars” Team Up to Protect Liver from Toxic Fat Buildup
November 18, 2016
A new study published online today in Cell Metabolism by a team led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism in the Perelman School of Medicine, revealed a surprising relationship between two molecules that works to store fat and promote fat burning for energy.